comparemela.com

Latest Breaking News On - Company biologics license application - Page 4 : comparemela.com

Citius Pharmaceuticals (CTXR) Resubmits the BLA for LYMPHIR

Citius Pharmaceuticals (CTXR) Resubmits the BLA for LYMPHIR
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Citius pharmaceuticals incDrug administrationCompany biologics license applicationCitius pharmaceuticalsBiologics license applicationComplete response letterDrug evaluationPrescription drug user fee act

Citius Pharmaceuticals, Inc Receives Regulatory Guidance from the U S Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR™

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) is pleased to announce the Company has received additional guidance.

Greg salsburgIlanit allenLeonard mazurDrug administrationPrnewswire citius pharmaceuticals incCompany nasdaqExchange commissionSecurities exchangeCitius pharmaceuticals incCompany biologics license applicationBiologics license applicationCitius pharmaceuticalsFast trackSecurities actSecurities exchange actAnnual report

Citius Pharmaceuticals (CTXR) Receives Regulatory Guidance from the FDA for the Planned Resubmission of the BLA for LYMPHIR

Citius Pharmaceuticals (CTXR) Receives Regulatory Guidance from the FDA for the Planned Resubmission of the BLA for LYMPHIR
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Leonard mazurCitius pharmaceuticals incDrug administrationCompany biologics license applicationCitius pharmaceuticalsBiologics license application

vimarsana © 2020. All Rights Reserved.